Lager Joanne Jenkins
Insider CIK 1816215 · ITOS Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2023-03-09 | 2023-03-10 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2022-03-11 | 2022-03-14 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-03-11 | 2022-03-14 | 3,500 | — | $0 | 178,938 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-03-11 | 2022-03-14 | 3,500 | $4.30 | $15.1K | 3,500 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-03-11 | 2022-03-14 | 3,500 | $36.01 | $126.0K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-02-11 | 2022-02-14 | 3,500 | — | $0 | 182,438 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-02-11 | 2022-02-14 | 1,982 | $35.52 | $70.4K | 1,518 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-02-11 | 2022-02-14 | 1,518 | $36.27 | $55.1K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-02-11 | 2022-02-14 | 3,500 | $4.30 | $15.1K | 3,500 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-01-14 | 2022-01-18 | 3,500 | — | $0 | 185,938 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-14 | 2022-01-18 | 723 | $39.58 | $28.6K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-14 | 2022-01-18 | 2,777 | $39.25 | $109.0K | 723 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-01-14 | 2022-01-18 | 3,500 | $4.30 | $15.1K | 3,500 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-01-03 | 2022-01-04 | 7,000 | — | $0 | 189,438 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-04 | 7,000 | $51.90 | $363.3K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-01-03 | 2022-01-04 | 7,000 | $4.30 | $30.1K | 7,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-12-17 | 2021-12-17 | 7,000 | — | $0 | 196,438 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-12-17 | 2021-12-17 | 7,000 | $4.30 | $30.1K | 7,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-17 | 2021-12-17 | 7,000 | $41.00 | $287.0K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-12-10 | 2021-12-10 | 3,500 | — | $0 | 203,438 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-12-10 | 2021-12-10 | 3,500 | $4.30 | $15.1K | 3,500 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-10 | 2021-12-10 | 3,500 | $34.50 | $120.8K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-11-18 | 2021-11-19 | 28,000 | — | $0 | 206,938 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-18 | 2021-11-19 | 28,000 | $34.50 | $966.0K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-11-18 | 2021-11-19 | 28,000 | $4.30 | $120.4K | 28,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-06-24 | 2021-06-25 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 122,000 | — | $0 | 122,000 | SEC↗ |